Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-22

Clinical Trial Update: Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

View source ↗

Summary

An observational study evaluating the effect of PegIntron plus Rebetol in chronic hepatitis C patients with genotype 1 and low viral load; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PegIntron (pegylated interferon alfa-2b)
  • Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Status: COMPLETED | Results posted: 2012-08-22